Current Ratio of Vir Biotechnology, Inc. from 30 Jun 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Vir Biotechnology, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2020 to 30 Sep 2025.
  • Vir Biotechnology, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 745%, a 29% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Vir Biotechnology, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 745% -302% -29% 30 Sep 2025
Q2 2025 784% -304% -28% 30 Jun 2025
Q1 2025 898% -89% -9% 31 Mar 2025
Q4 2024 1055% +326% +45% 31 Dec 2024
Q3 2024 1046% +427% +69% 30 Sep 2024
Q2 2024 1088% +484% +80% 30 Jun 2024
Q1 2024 987% +450% +84% 31 Mar 2024
Q4 2023 729% +239% +49% 31 Dec 2023
Q3 2023 620% +137% +28% 30 Sep 2023
Q2 2023 604% +177% +42% 30 Jun 2023
Q1 2023 537% +112% +26% 31 Mar 2023
Q4 2022 490% +75% +18% 31 Dec 2022
Q3 2022 483% +43% +9.8% 30 Sep 2022
Q2 2022 426% -83% -16% 30 Jun 2022
Q1 2022 426% -114% -21% 31 Mar 2022
Q4 2021 414% -483% -54% 31 Dec 2021
Q3 2021 440% -453% -51% 30 Sep 2021
Q2 2021 509% -281% -36% 30 Jun 2021
Q1 2021 539% 31 Mar 2021
Q4 2020 897% 31 Dec 2020
Q3 2020 892% 30 Sep 2020
Q2 2020 790% 30 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.